Taysha Gene Therapies (TSHA) Earnings Date & Reports

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TSHA is expected to report earnings to fall 1.25% to -11 cents per share on August 17

Taysha Gene Therapies TSHA Stock Earnings Reports

Q2'26

Est.

$-0.12

Q1'26

Missed

by $0.02

Q4'25

Beat

by $0.02

Q3'25

Est.

$-0.09

Q2'25

Missed

by $0.01

The last earnings report on May 06 showed earnings per share of -11 cents, missing the estimate of -10 cents. With 815.88K shares outstanding, the current market capitalization sits at 1.88B.

View a ticker or compare two or three

Compare

TSHA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for TSHA